MIM
ANIK icon

Meros Investment Management’s Anika Therapeutics ANIK Stock Holding History

Meros Investment Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-173,489
Closed -$2.61M – 43
2025
Q1 		$2.61M Sell
173,489
-4,186
-2% -$69.6K 1.53% 29
2024
Q4 		$2.92M Sell
177,675
-59,620
-25% -$1.18M 1.31% 32
2024
Q3 		$5.86M Buy
237,295
+24,581
+12% +$637K 2.65% 17
2024
Q2 		$5.39M Buy
212,714
+42,587
+25% +$1.1M 2.55% 16
2024
Q1 		$4.32M Buy
170,127
+120,178
+241% +$2.91M 1.93% 24
2023
Q4 		$1.13M Buy
+49,949
New +$1.03M 0.54% 39

Other funds holding ANIK

TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return

Meros Investment Management's ANIK Position: Q2 2025 in Review

Meros Investment Management sold out of Anika Therapeutics (ANIK) in Q2 2025, closing a stake of 173,489 shares — an estimated $2.61M sold.

Meros Investment Management first reported a position in ANIK in Q4 2023 and held it in 6 quarters. The position peaked at $5.86M in Q3 2024. 103 funds tracked by Wall St. Rank hold ANIK as of Q2 2025.

  • Meros Investment Management reported no remaining Anika Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Meros Investment Management sold 173,489 Anika Therapeutics shares in Q2 2025, an estimated $2.61M.
  • Meros Investment Management first reported a position in Anika Therapeutics in Q4 2023 and held it in 6 quarters.
  • Meros Investment Management's Anika Therapeutics position peaked at $5.86M in Q3 2024.
  • 103 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2025.

Based on Meros Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.